Genetic heterogeneity of hepatitis C virus and its clinical significance

Annals of Gastroenterology

Volumn 14, Issue 4, 2001, Pages 261-272

  Alexopoulou, Alexandra ^a,b  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Genotypes; Geographical distribution; Hepatitis C virus; Quasispecies; Subtypes

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; HEPATITIS C VACCINE; RIBAVIRIN; VIRUS RNA;

DISEASE COURSE; DISEASE SEVERITY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE STRUCTURE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; REVIEW; RISK FACTOR; SEROTYPE; VIRAL GENETICS; VIRUS IMMUNITY; VIRUS LOAD; VIRUS STRAIN;

EID: 34548295308     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Van Der Poel CL, Reesinck HW, Lelie PN, et al. Anti-hepatitis C antibodies and non-A non-B post transfusion hepatitis in The Netherlands. Lancet 1989; 2:297-298.
2. Papadimitropoulos V, Gionstozi A, Papaioannou C et al. Prevalence of HCV infection in the general population of various regions of Greece. In: Hepatitis C 1998. Hadziyannis SJ (ed), Athens 1998:163-170
3. Saeed AA, Admawi A, Al.Rasheed A, et al. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyandh. Lancet 1991; 338:459-460.
4. Alter AJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Eng J Med 1992; 327:1899-1905.
5. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C winth recombinant interferon alfa: A multi-center randomized, controlled trial. N Engl J Med 1989; 321:1506-1510.
6. Fattovich G, Giustina, G, Degos F et al. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. J Hepatol 1997; 27:201-205.
7. Tsukiyama-Kohara K, Likuza, N, Kohara M, Nomoto A. Internal ribosomal entry site within hepatitis C virus RNA. J Virol 1992; 66:1476-1483.
8. Weiner AJ, Brauer MJ, Rosenblatt J, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180:842-848.
9. Houghton M, Weiner A, Han J, et al. Molecular biology of the hepatitis C virus: implications for diagnosis development and control of viral disease. Hepatology 1991; 14:381-388.
10. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21:570-583.
11. Brechot C. Hepatitis C virus. Molecular biology and genetic variability. Dig Dis Sci 1996; 41:6S-21S.
12. Simmonds P, Mcomish F, Yap PL, et al. Sequence variability in the 5′ non coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74:661-668.
13. Simmonds P, Holmes EC, CHA TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J Gen Virol 1993; 74:2391-2399.
14. Simmonds P, Smith DB, Mcomish F, et al. Identification of genotypes of hepatitis C virus by sequence comparison in the core, E1 and NS5 regions. J Gen Virol 1994; 75:1053-1061.
15. Ohno T, Lau JYN. The gold standard accuracy and the current concepts. Hepatitis C virus genotype and viraemia. Editorial. Hepatology 1996; 24:1312-1315.
16. Smith Db, Pontisso P. Heterogeneity of hepatitis C virus. Baillere's Clin Gastroenterol 1996; 10:243-255.
17. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990; 170:1021-1025.
18. Okamoto H, Okada S, Sugiyama Y, et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol 1991; 72:2697-2704.
19. Okamoto H, Miyakawa Y, Mayumi M. Molecular virology of hepatitis C virus. Viral Hepat Rev 1997; 3:51-62.
20. Smith DB, Davidson F, Simmonds P. Hepatitis C virus variants and the role of genotyping. J Hepatol 1995; 23(suppl):26-31.
21. Simmonds P, Alberti A, Bonino F, et al. A proposedesystem for the nomenclature of hepatitis C virus genotypes. Hepatology 1994; 19:1321-1324.
22. Mcomish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32:884-892.
23. Kleter GEM, Van Doom U, Brouwer JT, et al. Sequence analysis of the 5′ untranslated region in isolates of at least four genotypes of hepatitis C virus in the Netherlands. J Clin Microbiol 1994; 32:306-310.
24. Nousbaum JB, Pol S, Nalbas B, et al. Hepatitis C virus 1b infection in France and Italy. Ann Intern Med 1995; 122:161-168.
25. Sinani C, Savvas S, Spanou E, et al. Epidemiology of HCV genotypes in Greece. In: Hepatitis C 1997. Hadziyannis SJ (ed). Athens 1997:189-197.
26. PM Kao JH, Tsai SL, Chen PJ, et al. A clinicopathological study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients. J Hepatol 1994; 21:244-249.
27. Greene WK, Cheong MK, NG V, Yap KW. Prevalence of hepatitis C virus sequence variants in South-East Asia. J Gen Virol 1995; 76:211-215.
28. Tokita H, Okamoto H, Tsuda F, et al. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth and nine major genetic groups. Proc Natl Acad Sci USA 1994; 91:11022-11026
29. Haushofer AC, Kopty C, Hauer R, et al. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 2001; 20:41-47.
30. Elghouzzi MH, Bouchardeau F, Pillonel J, et al. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive french blood donors. Vox Sang 2000; 79:138-144.
31. Forns X, Bukh J. Methods for determining the hepatitis C virus genotype. Viral Hepat Rev 1998; 4:1-19.
32. Blatt LM, Mutchnick MG, Tong MJ et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in United States. J Viral Hepat 2000; 7:196-202.
33. Zein NN, Rakela J & Persing DH. Genotype dependent serologic reactivities in patients infected with hepatitis C virus in the United States. Mayo Clin Proc 1995; 70:449-452.
34. Makris K, Kouvelis I, Drakopoulos E, et al. Frequency and characteristics of post-transfusionhepatitis in Greece with emphasis in hepatitis C: comparing second-and third generation assays. Transfus Med 1995; 5:213-224.
35. Pawlotsky JM. Measuring hepatitis C viraemia in clinical samples: Can we trust the assays? Hepatology 1997; 26:1-4.
36. Mellor J, Hawkins A, Simmonds P. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol 1999, 37:2525-2532.
37. Zekri AR, Bahnassy AA, Shaarawy SM, et al. Hepatitis C virus genotyping in relation to neu-oncoprotein overexpression and the development of hepatocellular carcinoma. J Med Microbiol 2000; 49:89-95.
38. Michitaka K, Durazzo M, Tillmann HL, et al. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology 1994, 106:1603-1610.
39. Zehender G, De Maddalena C, Monti G, et al. HCV genotypes in bone marrow and peripheral bloodmononuclear cells of patients with mixed cryoglobulinemia. Clin Exp Rheumatol 1995; 13(Suppl 13):S87-S90.
40. Poynard T, Leroy V, Cohard M. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C. effects of dose and duration. Hepatology 1996; 24:778-789.
41. Pawlotsky JM, Thorval FR, Bastie A. Factors affecting treatment responses to interferon-a in chronic hepatitis C. J ID 1996; 174:1-7.
42. Kobayashi Y, Watanabe S, Konishi M. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-b. Hepatology 1993; 18:1319-1325.
43. Conjeevaram HS, Everhart JE, Hoofnagle JH. Predictors of a sustained beneficial response to interferon alfa therapyvin chronic hepatitis C. Hepatology 1995; 22:1326-1329.
44. Pontisso P, Gerotto M, Chemello L. Hepatitis C virus genotypes HCV-1a and HCV-1b: the clinical point of view. J Infect Dis 1995; 171:760.
45. Chemello L, Bonetti P, Cavalletto L, et al. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology 1995; 22:700-706.
46. Davis GL, Lau JYN. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 1997; 26(suppl 1):122S-127S.
47. Davis GI, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339:1493-1439.
48. Reichard O, Norkrans G, Fryden A, et al. Randomized, double-blind, placebo controlled trial of interferon a-2b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351:83-87.
49. EASL international consensus conference on hepatitis C. Paris 26-28 February 1999. Consensus statement. J Hepatol 1999; 30:956-961.
50. Zylbeberg H, Chaix ML, Brechot C. Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-a. Ann Intern Med 2000; 132:845-846.
51. Enomoto N, Sakuma I, Asahina Y. Mutations in the non-structural protein 5A gene and response to Interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334:77-81.
52. Tanji Y, Kaneko T, Shimotohno K. Phosphorylation of hepatitis C virus-encoded non-structural protein NS5. J Virol 1995; 69:3980-3986.
53. Liaw YF, Lee CS, Tsai SL. T-cell mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995; 22:1368-1373.
54. Ballardini G, Groff P, Pontisso P, et al. Hepatitis C virus (HCV genotype, tissue HCV antigens hepatocellular expression of HLA-A, B, C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest 1995; 95:2067-2075.
55. Missale G, Cariani E, Lamonaca, V, et al. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b and genotpe 2c-infected patients. Hepatology 1997; 26:792-797.
56. Buratti E, Gerotto M, Pontisso P, et al. In vivo translational efficiency of different hepatitis C virus 5′-UTRs. FEBS Lett 1997; 411:275-180.
57. Matsumoto M, Hsieh TY, Zhu N, et al. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin betaR. J Virol 1997; 71:1301-1309.
58. Mondelli MU, Cerino A, Lisa A, et al. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune mediated sequence variation. Hepatology 1999; 30:537-545.
59. Neumann AU, Lam NP, Dahari H et al. Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. J Infect Dis 2000; 182:28-35.
60. Di Martino V, Brenot C, Samuel D et al. Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on FAS-mediated apoptosis after liver transplantation for hepatitis C. Transplantation 2000; 70:1390-1396.
61. Rodriguez-Lopez M, Riezu Boj JI, Ruiz M, et al. Immunogenicity of variable regions of hepatitis C virus proteins: selection of peptide epitopes to assess hepatitis C virus genotypes by Elisa. J Gen Virol 1999; 80:727-738.
62. Kurosaki M, Enomoto N, Marumo F, Sato C. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Virology 1994; 205:161-169.
63. Kato N, Sekiya H, Ootsuyama Y, et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J virol 1993; 67:3923-3930.
64. Weiner A, Erickson Al, Kansopon J, et al. Persistent hepatitis C virus infection is a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape T lymphocyte escape mutant. PNAS USA 1995; 92:2755-2759.
65. Honda M, Kaneko S, Sakai A, et al. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 1994; 20:1144-1151.
66. Moribe T, Hayashi N, Kanazawa Y, et al. Hepatitis C viral complexity detected by single-strand conformationpolymorphism response to interferon therapy. Gastroenterology 1995; 108:789-795.
67. Pelletier SJ, Raymond DP, Crabtree TD et al. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation. Hepatology 2000; 32:375-381.
68. Farzi P, Shimoda A, Colana A et al. The outcome of acue hepatitis C predicted by the evolution of the viral quasispecies. Science 2000; 288:339-344.
69. Allander T, Gruber A, Naghavi M, et al. Frequent patient to patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345:603-607.
70. Bronowicki JP, Venard V, Botte C, et al. Patient-to-patient transmission of hepatitis C during colonoscopy. N Engl J Med 1997; 337:237-240
71. Katsoulidou A, Paraskevis D, Kalapothaki V, et al. Molecularepidemiology of a hepatitis C outbreak in a haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1999; 14:1188-1194.
72. Farci P, Alter HJ, Gonvidarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258:135-140.
73. Farci P, Alter Hj, Wong DC, et al. Pevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. PNAS USA 1994; 91:779-786.
74. Weiner A, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. PNAS 1992; 89:3468-3472
75. Choo QI, Kuo G, Ralston R, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994; 91:1294-1298.
76. Lechmann M, Liang J. Vaccine development for hepatitis C. Sem liver Dis 2000; 20:211-226.
77. Pozzato G, Kaneko S, Moretti M, et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994; 43:291-296.
78. Mita E, Hayashi N, Kanazawa Y, et al. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol 1994; 21:468-473.
79. Feray C, Gigou M, Samuel D, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver-transplantion. Gastroenterology 1995; 108:1088-1096.
80. Cathomas G, McGandy CE, Terraciano LM, et al. Detection and typing of hepatitis C RNA in liver biopsies and its relation to histopathology. Virchows Arch 1996; 429:353-358.
81. Caccamo L, Gridelli B, Sampietro M, et al. Hepatitis C virus genotypes and reinfection of the graft during long-term follow-up in 35 liver transplant recipients. Transpl Int 1996; 9:S204-S209.
82. Silini E, Bottelii R, Asti M. Hepatitis C virus genotypes and risk for hepatocellular carcinomi in cirrhosis: a case-control study. Gastroentorology-1996; 111:199-205.
83. Gane EJ, Naoumov NV, Qian KP. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110:167-177.
84. Simmonds P, Mellor J, Craxi A. Epidemiological clinical and therapeutic association of hepatitis C types in western European patients. J Hepatol 1996; 24:517-524.
85. Zein NN, Poteruch JJ, Gross JB, et al. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am J Gastroenterol 1996; 91:2560-2562.
86. Zein NN, Rakela J, Krawitt EL, et al. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative study Group.Ann Intern Med 1996; 125:634-639.
87. Hatzakis A, Katsoulidou A, Kaklamani E at al. Hepatitis C virus 1b is the dopminant genotype in HCV-related carcinogenesis: a case control study. Int J Cancer 1996; 68:51-53.
88. Kobayashi M, Tanaka E, Sodeyama T, et al The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23:695-699.
89. Booth JC, Foster GR, Levine T, et al. The relationship of histology to genotype inchronic HCV infection. Liver 1997; 17:144-151.
90. Gordon FD, Poterucha JJ, Germer J et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantatio. Transplantation 1997; 63:1419-1423.
91. Donato F, Tagger A, Chiesa R et al. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case control study in Italy. Hepatol 1997; 26:579-584.
92. Bruno S, Silini E, Crosignani A, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25:754-758.
93. Pageaux GP, Ducos J, Mondain AM, et al. Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver translant recipients. Liver Transpl Surg 1997; 3:501-505.
94. Tassopoulos NC, Papatheodoridis GV, Katsoulidou A, et al. Factors associated with severity and disease progression in chronic hepatitis C. Hepatogastroenterol 1998; 45:1678-83.
95. Berg T, Hopf U, Bechstein WO, et al. Pretransplant viriological markers hepatitis C virus genotype and viraemia level are not helpful in predicting individual outcome after orthotipic liver transplantation. Tranplantation 1998; 66:225-228.
96. Bellentani S, Ponzato G, Saccoccio G, et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 1999; 44:874-880.
97. Prieto M, Berenguer M, Ryon JM, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation:relationship with rejection episodes. Hepatol 1999; 29:250-256.
98. Belli LS, Zavaglia C, Alberti AB, et al. Influence of immunogenetic backround on the outcome of recurrent hepatitis C after liver transplantation. Hepatol 2000; 31:1345-1350.
99. Yamada M, Kakumu S, Yoshioka K, et al. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994; 39:234-239.
100. Yotsuyanagi H, Koike k, Yasuda K et al. Hepatitis C virus genotypes and development of hepatocellular carcinoma. Cancer 1995; 76:1352-1355.
101. Takano S, Yokosuka O, Imazeki F, et al. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995; 21:650-655.
102. Zhou S, Terrault NA, Ferrell L, et al. Severity of liver diseasein liver transplantation recipientas with hepatitis C virus infection: relationshipto genotype and level of viraemia. Hepatol 1996; 24:1041-1046.
103. Guido M, Rugge M, Thung SN, et al. Hepatitis virus serotypes and liver pathology. Liver 1996; 16:353-357.
104. Lee DS, Sung YC, Whang YS. Distribution of HCV Genotypes among blood donors, patients with chronic liver disease, hepatocellular carcinoma, and patients on maintenance hemodialysis in Korea. J Med Virol 1996; 49:55-60.
105. Zeuzeum S, Franke A, Lee JH, et al. Phylogenetic analysis of hepatitis C virus isolates andtheir correlation to viraemia, liver function tests and histology. Hepatol 1996; 24:1003-1009.
106. Romeo R, Colombo M, Rumi M, et al. Lack of association between type of hepatitis C virus, serum load and severity of liver disease. J Viral Hepat 1996; 3:183-190.
107. Lau JYN, Davis GL, Prescott LE, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann Intern Med 1996; 124:868-876.
108. Boker KH, Dalley G, Bahr G et al. Long-term outcome of hepatitis C virus infection after liver transplantation, Hepatol 1997, 25:203-210.
109. Mangia A, Cascavilla I, Lezzi G et al. HCV genotypes in patients with liver disease of different stages and severity. J Hepatol 1997; 26:1173-1178.
110. Benvegnu L, Pontisso P, Cavalletto D, et al. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus related cirrhosis. Hepatology 1997; 25:211-215.
111. Lopez-Labrador FX, Ampurdanes S, Forns X. Hepatitis C virus (HCV) genotypes in Spanish patiepts with HCV infection: relatiońship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997; 27:959-965.
112. Naoumov NV, Chokshi S, Metivier F, et al. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis. J Hepatol 1997; 27:331-336.
113. Gayowski T, Singh N, Marino FR, et al. Hepatitis C virus genotypes in liver transplant recipients: impact on post-transplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997; 64:422-426.
114. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349:825-832.
115. Serfaty L. Aumaitre H, Chazouilleres O, et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998:27:1435-1440.
116. Vargas HE, Laskus T, Wang LF, et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver transpl Surg 1998; 4:22-27.
117. De Moliner L, Pontisso P, De Salvo GL, et al. Serum and liver HCV RNA in patients with chronic hepatitis C: correlation with clinical and histological features. Gut 199; 42:856-860.
118. Meter B, Brouwer JT, Nevens F, et al. Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. Liver 1998; 18:32-38.
119. Roffi L, Ricci A, Ogliari C et al. HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients. J Hepatol 1998; 29:701-706.
120. Costes V, Durand L, Pageaux GP et al. Hepatitis C virus genotypes and quantification of hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C. Am J Clin Pathol 1999; 111:252-258.
121. Dutta Ubyth F., Kench J et al. Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control study. Aust N Z J Med 1999; 29:300-307.
122. Reid AE, Koziel MJ, Aiza I, et al. Hepatitis C virus genotypes and viraemia and hepatocellular carcinoma in the United States. Am J Gastroenterol 1999; 94:1619-1626.
123. Adinolfi LE, Utili R, Andreana A, et al. Eur J Gastroenterol Hepatol; 2000: 12:389-304.